Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082001 | SCV000113936 | pathogenic | not provided | 2013-10-24 | criteria provided, single submitter | clinical testing | |
Center of Genomic medicine, |
RCV000710048 | SCV000840426 | pathogenic | Leber congenital amaurosis | 2018-04-13 | criteria provided, single submitter | clinical testing | This variant was identified in combination with another variant in the same gene (compound heterozygosity) in patient with Leber congenital amaurosis. |
Genome- |
RCV001800386 | SCV002045231 | pathogenic | Leber congenital amaurosis 6 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001800387 | SCV002045242 | pathogenic | Cone-rod dystrophy 13 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857395 | SCV002235173 | pathogenic | Cone-rod dystrophy 13; Leber congenital amaurosis 6 | 2022-06-20 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 95949). This variant has not been reported in the literature in individuals affected with RPGRIP1-related conditions. This variant is present in population databases (rs398124354, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Trp925*) in the RPGRIP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1 are known to be pathogenic (PMID: 11528500, 23105016). |